{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:31Z","timestamp":1792782691648,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Technical Research Project Funding by Huazhong University of Science and Technology","award":["No.HZKJSYJSXM2024M100"],"award-info":[{"award-number":["No.HZKJSYJSXM2024M100"]}],"id":[{"id":"https:\/\/ror.org\/00p991c53","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04954-1","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:31:01Z","timestamp":1789630261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting ALDH2 with Alda-1 to reverse cisplatin resistance in lung adenocarcinoma"],"prefix":"10.1007","volume":"96","author":[{"given":"Meidong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"4","key":"4954_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS et al (2024) Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 22(4):249\u2013274. https:\/\/doi.org\/10.6004\/jnccn.2204.0023","journal-title":"J Natl Compr Canc Netw."},{"issue":"3","key":"4954_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101374","volume":"12","author":"Y Shen","year":"2024","unstructured":"Shen Y, Chen JQ, Li XP (2024) Differences between lung adenocarcinoma and lung squamous cell carcinoma: driver genes, therapeutic targets, and clinical efficacy. Genes Dis 12(3):101374","journal-title":"Genes Dis"},{"key":"4954_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-981-13-6260-6_13","volume":"1193","author":"LS Wang","year":"2019","unstructured":"Wang LS, Wu ZX (2019) ALDH2 and cancer therapy. Adv Exp Med Biol 1193:221\u2013228","journal-title":"Adv Exp Med Biol"},{"key":"4954_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-981-13-6260-6_3","volume":"1193","author":"CH Chen","year":"2019","unstructured":"Chen CH, Ferreira JCB, Mochly-Rosen D (2019) ALDH2 and cardiovascular disease. Adv Exp Med Biol 1193:53\u201367","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"4954_CR5","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.apsb.2021.02.008","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang H, Fu L (2021) The role of ALDH2 in tumorigenesis and tumor progression: targeting ALDH2 as a potential cancer treatment. Acta Pharm Sin B 11(6):1400\u20131411","journal-title":"Acta Pharm Sin B"},{"issue":"7","key":"4954_CR6","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.7150\/ijbs.93075","volume":"20","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Lin XH, Guo HY et al (2024) Multi-omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. Int J Biol Sci 20(7):2763\u20132778","journal-title":"Int J Biol Sci"},{"issue":"8","key":"4954_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1349-7006.2001.tb01178.x","volume":"92","author":"JF Beck","year":"2001","unstructured":"Beck JF, Br\u00fcgger D, Brischwein K et al (2001) Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias. Jpn J Cancer Res 92(8):896\u2013903","journal-title":"Jpn J Cancer Res"},{"key":"4954_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.freeradbiomed.2024.08.026","volume":"224","author":"G Shan","year":"2024","unstructured":"Shan G, Bian Y, Yao G et al (2024) Targeting ALDH2 to augment platinum-based chemosensitivity through ferroptosis in lung adenocarcinoma. Free Radic Biol Med 224:310\u2013324","journal-title":"Free Radic Biol Med"},{"key":"4954_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.lfs.2016.01.028","volume":"147","author":"R Li","year":"2016","unstructured":"Li R, Zhao Z, Sun M, Luo J, Xiao Y (2016) ALDH2 gene polymorphism in different types of cancers and its clinical significance. Life Sci 147:59\u201366","journal-title":"Life Sci"},{"issue":"15","key":"4954_CR10","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.2174\/1389450116666150727115118","volume":"18","author":"R Zhang","year":"2017","unstructured":"Zhang R, Wang J, Xue M, Xu F, Chen Y (2017) ALDH2\u2014the genetic polymorphism and enzymatic activity regulation: their epidemiologic and clinical implications. Curr Drug Targets 18(15):1810\u20131816","journal-title":"Curr Drug Targets"},{"issue":"1","key":"4954_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2013","volume":"94","author":"CH Chen","year":"2014","unstructured":"Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D (2014) Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev 94(1):1\u201334. https:\/\/doi.org\/10.1152\/physrev.00017.2013","journal-title":"Physiol Rev"},{"issue":"11","key":"4954_CR12","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1021\/tx500312g","volume":"27","author":"SS Drzymala","year":"2014","unstructured":"Drzymala SS, Herrmann AJ, Maul R, Pfeifer D, Garbe LA, Koch M (2014) In vitro phase I metabolism of cis-zearalenone. Chem Res Toxicol 27(11):1972\u20131978","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"4954_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167863","volume":"1871","author":"Z Sun","year":"2025","unstructured":"Sun Z, Jiang W, Lu G et al (2025) Loss of ALDH2 accelerates the progression of pulmonary arterial hypertension through the 4-HNE\/ERK1\/2-p16INK4a signaling pathway. Biochim Biophys Acta Mol Basis Dis 1871(6):167863","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"28","key":"4954_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301852","volume":"10","author":"L Liu","year":"2023","unstructured":"Liu L, Pang J, Qin D et al (2023) Deubiquitinase OTUD5 as a Novel Protector against 4-HNE-Triggered Ferroptosis in Myocardial Ischemia\/Reperfusion Injury. Adv Sci (Weinh) 10(28):e2301852","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"4954_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121798","volume":"11","author":"BB Martins","year":"2021","unstructured":"Martins BB, H\u00f6sch NG, Alcantara QA et al (2021) Activation of PKC\u03b5-ALDH2 axis prevents 4-HNE-induced pain in mice. Biomolecules 11(12):1798","journal-title":"Biomolecules"},{"issue":"1","key":"4954_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41570-6","volume":"14","author":"YC Chang","year":"2023","unstructured":"Chang YC, Lee HL, Yang W et al (2023) A common East-Asian ALDH2 mutation causes metabolic disorders and the therapeutic effect of ALDH2 activators. Nat Commun 14(1):5971","journal-title":"Nat Commun"},{"issue":"8","key":"4954_CR17","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.ajpath.2024.04.008","volume":"194","author":"Y Wei","year":"2024","unstructured":"Wei Y, Gao S, Li C et al (2024) Aldehyde dehydrogenase 2 deficiency aggravates lung fibrosis through mitochondrial dysfunction and aging in fibroblasts. Am J Pathol 194(8):1458\u20131477","journal-title":"Am J Pathol"},{"issue":"7","key":"4954_CR18","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1096\/fj.201902550RRR","volume":"34","author":"SH Tsai","year":"2020","unstructured":"Tsai SH, Hsu LA, Tsai HY et al (2020) Aldehyde dehydrogenase 2 protects against abdominal aortic aneurysm formation by reducing reactive oxygen species, vascular inflammation, and apoptosis of vascular smooth muscle cells. FASEB J 34(7):9498\u20139511","journal-title":"FASEB J"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04954-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04954-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04954-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:31:02Z","timestamp":1789630262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04954-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4954"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04954-1","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"6 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal Experiments. Approved by the Institutional Animal Care and Use Committee (IACUC), Peking University (Approval Code: IACUC\u201320220707\u201348MTD) (The animal experiments were completed at the Animal Experiment Platform of the National Protein Science Center in Beijing by Dr Sailong Ma and Xizhen Xu when they were jointly-supervised doctoral students). Euthanasia was performed by carbon dioxide inhalation, in accordance with the AVMA Guidelines for the Euthanasia of Animals. Specifically, animals were placed in their home cage and transferred to a dedicated induction chamber. Carbon dioxide was introduced from a compressed gas cylinder at a controlled fill rate of approximately 10% to 30% of the chamber volume per minute to minimize distress. The flow was maintained for at least 5\u00a0min after respiratory arrest to ensure death. All efforts were made to minimize animal suffering throughout the experiment.All procedures strictly followed the Guide for the Care and Use of Laboratory Animals (NIH, 8th edition) and international animal welfare standards. 2. Human Subjects Research Approved by the Medical Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (Approval Code: TJ-IRB202406046). The study was conducted in compliance with the Declaration of Helsinki (2013 revision) and the National ethical regulations of China. Due to the retrospective nature of the study and the use of anonymous residual samples from routine diagnostics, the requirement for written informed consent was formally waived by the reviewing ethics committee.","order":1,"name":"Ethics","label":"Ethic approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"103"}}